NCT03509688View on ClinicalTrials.gov

The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Hepatitis
Interventions
DRUG

entecavir+resveratrol

entecavir+resveratrol

DRUG

Entecavir

Entecavir

DRUG

entecavir+thymosin α1

entecavir+thymosin α1

Sponsors
All Listed Sponsors
collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

The First Hospital of Jilin University

OTHER

NCT03509688 - The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial | Biotech Hunter | Biotech Hunter